Allogene Therapeutics Inc (ALLO)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
May 31, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Allogene Therapeutics Cash and Short Term Investments (Quarterly): 384.86M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 384.86M |
December 31, 2023 | 448.70M |
September 30, 2023 | 465.50M |
June 30, 2023 | 491.96M |
March 31, 2023 | 471.22M |
December 31, 2022 | 517.32M |
September 30, 2022 | 552.23M |
June 30, 2022 | 490.49M |
March 31, 2022 | 449.05M |
December 31, 2021 | 457.30M |
September 30, 2021 | 483.48M |
June 30, 2021 | 587.71M |
Date | Value |
---|---|
March 31, 2021 | 699.58M |
December 31, 2020 | 827.91M |
September 30, 2020 | 841.02M |
June 30, 2020 | 899.65M |
March 31, 2020 | 492.92M |
December 31, 2019 | 530.53M |
September 30, 2019 | 501.24M |
June 30, 2019 | 502.42M |
March 31, 2019 | 466.14M |
December 31, 2018 | 459.38M |
September 30, 2018 | 244.22M |
June 30, 2018 | 293.93M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
384.86M
Minimum
Mar 2024
899.65M
Maximum
Jun 2020
554.76M
Average
497.08M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 238.25M |
Vaxart Inc | 36.66M |
Agenus Inc | 52.86M |
BioCryst Pharmaceuticals Inc | 336.55M |
Stereotaxis Inc | 17.63M |